Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04144517
Title A Study of ALKS 4230 With Pembrolizumab in Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alkermes, Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.